- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06355947
Cycling and Treadmill With Dual Task for Parkinson's Disease Improvement
Cycling Induced Motor Cortex Plasticity and Functional Improvement -the Dual Task Evaluation Model for Parkinson Disease
Motor impairment in lower extremities is common in individuals with Parkinson disease (PD). Development sensitive test for early motor deviations is important. Conventional walking test cannot induce the PD related motor impairments, such as freezing of gait. Therefore, finding a safe substitute test to induce PD related motor impairments is important.
Studies showed that working memory related dual task walking was a sensitive test for PD. However, the optimal cognitive test needs to be clarified. Studies also showed that the neuromuscular control mechanism of leg movements during cycling were similar to those during walking. Therefore, dual task cycling test is potential to be a safe and sensitive testing model.
Studies showed that exercise could improve cognitive function and induce brain plasticity. Dual task exercise training was shown to be more effective than single task exercise training for older people to prevent fall. Whether the added cognitive task could improve to detriment brain plasticity in PD should be investigated. Transcranial magnetic stimulation can evaluate the motor cortex plasticity on-invasively and can evaluate the exercise induced brain plasticity.
The purpose of this three-year project is to develop PD-sensitive. The purposes of the first year are to translate the dual task walking test to dual task cycling test, and to establish the reliability of the dual task cycling test.
The purposes of the second year are to compare the motor cortex plasticity induced by single task cycling versus dual task cycling and to compare the difference response between PD and healthy control people.
The purpose of the third year is to evaluate the effect of 8 week long term cycling training or treadmill training of individuals with PD on motor cortex plasticity, dual task performance, and ambulation ability.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Taoyuan, Taiwan, 333
- Chang Gung University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Health subjects:
Exclusion Criteria:
- Musculoskeletal injuries on legs.
- Osteoporosis.
PD subjects:
Inclusion Criteria:
- Clinical diagnosis of Parkinson disease.
Exclusion Criteria:
- Musculoskeletal injuries on legs
- Osteoporosis.
- Any peripheral or central nervous system injury or disease patients.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Stage 3:PD Control group
Control group
|
|
No Intervention: Stage 1:Healthy people
To establish a baseline and ensure reliability, and to explore the relationship between dual-task gait performance and dual-task cycling
|
|
No Intervention: No Intervention: Stage 2:PD people
To explore the relationship between dual-task gait and dual-task cycling performances in individuals with Parkinson's Disease (PD)
|
|
Experimental: Stage 3:PD cycling training group
Cycling training conducted with cognitive tasks
|
Cycling training conducted with cognitive tasks
|
Experimental: Stage 3: PD treadmill training group
Treadmill training conducted with cognitive tasks
|
Treadmill training conducted with cognitive tasks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Walking Speed
Time Frame: Baseline, 4 weeks and 8 weeks
|
The time taken by participants to walk a standardized distance, typically expressed in centimeters per second (cm/s).
|
Baseline, 4 weeks and 8 weeks
|
Step Length
Time Frame: Baseline, 4 weeks and 8 weeks
|
The linear distance between the two ankles, typically expressed in centimeters(cm).
|
Baseline, 4 weeks and 8 weeks
|
Step Time
Time Frame: Baseline, 4 weeks and 8 weeks
|
The duration taken for one complete step, measuring from foot-off of one foot to the next foot-off of the same foot, usually expressed in seconds.
|
Baseline, 4 weeks and 8 weeks
|
Power Spectral Density (PSD)
Time Frame: Baseline, 4 weeks and 8 weeks.
|
Quantifies the power of EEG signals within specific frequency bands (e.g., delta, theta, alpha, beta, and gamma) over a period.
|
Baseline, 4 weeks and 8 weeks.
|
Task Accuracy
Time Frame: Baseline, 4 weeks and 8 weeks.
|
The percentage of correct responses or actions made by participants in response to walking or cycling tasks.
|
Baseline, 4 weeks and 8 weeks.
|
Reaction Time
Time Frame: Baseline, 4 weeks and 8 weeks.
|
The duration between the onset of task start time and the participant's response to it, typically expressed in second (s).
|
Baseline, 4 weeks and 8 weeks.
|
Balance Performance
Time Frame: Baseline, 4 weeks and 8 weeks
|
Measured by the duration the stance can be maintained, typically expressed second.
|
Baseline, 4 weeks and 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Double Support Time
Time Frame: Baseline, 4 weeks and 8 weeks
|
The portion of the gait cycle where both feet are in contact with the ground, indicating the transition phase between steps, expressed as a percentage of the gait cycle or in seconds.
|
Baseline, 4 weeks and 8 weeks
|
Single Support Time
Time Frame: Baseline, 4 weeks and 8 weeks
|
The duration within the gait cycle when only one foot is in contact with the ground, typically measured in seconds or as a percentage of the total gait cycle.
|
Baseline, 4 weeks and 8 weeks
|
Swing Time
Time Frame: Baseline, 4 weeks and 8 weeks
|
The portion of the gait cycle where the foot is not in contact with the ground, moving forward to the next step.
It is usually expressed as a percentage of the total gait cycle or in seconds.
|
Baseline, 4 weeks and 8 weeks
|
Stance Time
Time Frame: Baseline, 4 weeks and 8 weeks
|
The portion of the gait cycle when the foot is in contact with the ground, supporting body weight.
It's typically expressed as a percentage of the total gait cycle or in seconds
|
Baseline, 4 weeks and 8 weeks
|
Cadence
Time Frame: Baseline, 4 weeks and 8 weeks
|
The number of steps an individual takes per minute, providing an overview of gait speed and rhythm, , expressed as steps per minute.
|
Baseline, 4 weeks and 8 weeks
|
Heart rate
Time Frame: Baseline
|
The number of heartbeats per minute on resting, walking or cycling tasks.
|
Baseline
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 103-7445B
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease(PD)
-
University of FloridaCompletedParkinson Disease (PD)United States
-
Chang Gung UniversityCompleted
-
IRCCS San Raffaele RomaCompletedParkinson Disease (PD) | Paralysis; SupranuclearItaly
-
Altec Inc.National Institute of Neurological Disorders and Stroke (NINDS)RecruitingParkinson Disease(PD)United States
-
Federal University of Rio Grande do SulCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.; University of...CompletedParkinson Disease(PD)Brazil, United Kingdom
-
AbbVieCompletedParkinson Disease (PD)Canada
-
Stanford UniversityCompleted
-
Boehringer IngelheimCompletedEarly Parkinson Disease (Early PD)United States, Argentina, Austria, Czech Republic, Finland, Germany, Hungary, India, Japan, Malaysia, Russian Federation, Slovakia, Taiwan, Ukraine
-
Chang Gung UniversityRecruitingParkinson Disease(PD)Taiwan
-
Chang Gung UniversityCompletedParkinson Disease(PD)Taiwan
Clinical Trials on Cognitive cycling training
-
Chang Gung Memorial HospitalCompletedSafety and Effectiveness
-
Chang Gung Memorial HospitalRecruitingEccentric Exercise TrainingTaiwan
-
University of VigoCompleted
-
Arizona State UniversityMayo Clinic; University of Minnesota; University of Rochester; University of St...RecruitingMild Cognitive ImpairmentUnited States
-
University Medical Centre LjubljanaSlovenian Research AgencyUnknownKidney Diseases | Chronic Kidney Diseases | Physical Activity | End Stage Renal Disease | Kidney FailureSlovenia
-
University of VigoRecruiting
-
Schön Klinik Berchtesgadener LandCompletedChronic Obstructive Pulmonary DiseaseGermany
-
Johns Hopkins UniversityHugo W. Moser Research Institute at Kennedy Krieger, Inc.CompletedSecondary Progressive Multiple SclerosisUnited States
-
Chang Gung UniversityRecruiting